Corporate$MRNAdeveloping · 5 wires7:21 AM ET

Moderna plans $2B convertible note offering; FDA clears updated COVID vaccines

Moderna is raising $2B via convertible senior notes due 2032, with an option for an extra $300M. The FDA also approved its updated 2026-2027 COVID-19 vaccines, including the new MnExSpike formula.

Sentimentbullish +70Bullish

Impact60medium

Confidence90%Corroborated reports

Eventdeveloping5 wires · v5

BORSA PLUS · EVENT INTELLIGENCE

The headline is open. The market meaning goes deeper.

Preview the analysis BORSA members receive around every material canonical event.

BORSAPLUSUnlock the intelligence behind the signal.

Create free account · 3 views/day

Also in Corporate

from the wire

Hewlett Packard Enterprise: it applied for and expects more tariff refundsbullish +65 · impact 30 · 8:27 AM

VW chief supervisor's compromise attempt before Friday board meeting failedbullish +40 · impact 10 · 8:24 AM

Nvidia and Hugging Face deal seen closing first half 2027bullish +50 · impact 80 · 8:19 AM

Xiaomi signs MOU with first batch of German auto dealer groupsbullish +65 · impact 30 · 8:05 AM